Ellicott City, MD, United States of America

Hanping Feng

USPTO Granted Patents = 9 

Average Co-Inventor Count = 3.3

ph-index = 2

Forward Citations = 29(Granted Patents)


Location History:

  • Framingham, MA (US) (2012)
  • Ellicott City, MD (US) (2015 - 2024)

Company Filing History:


Years Active: 2012-2025

Loading Chart...
9 patents (USPTO):Explore Patents

Title: Innovator Hanping Feng: Pioneering Treatments for Clostridium Difficile Infections

Introduction: Hanping Feng, an accomplished inventor based in Ellicott City, MD, is renowned for his significant contributions to biomedical research and therapeutic innovations. With a remarkable portfolio of 8 patents, he has focused on developing advanced methods and compositions for combating Clostridium difficile infections, addressing a critical medical need.

Latest Patents: Among Hanping Feng's latest inventions are two noteworthy patents that showcase his innovative approach to treatment. The first is titled "Protein inhibitors of Clostridium difficile toxin B," which outlines methods for treating or preventing infections through the administration of antitoxins. This approach includes the use of designed ankyrin repeat proteins (DARPins) as antitoxins, highlighting the potential for targeted therapy. The second patent, "Humanized tetra-specific octavalent antibody against Clostridium difficile toxin A and B," describes novel antibody-based binding agents derived from camelid VH and human immunoglobulins. These agents exhibit specificity towards toxins A and B, providing effective treatment options for primary and recurrent Clostridium difficile infections.

Career Highlights: Hanping Feng has built a distinguished career in research and development, working at prestigious institutions, including the University System of Maryland and Tufts University. His expertise and dedication to advancing medical treatments have established him as a leader in his field.

Collaborations: Throughout his career, Hanping has collaborated with esteemed colleagues, including Yongrong Zhang and Charles Bix Shoemaker. These partnerships have fostered a rich exchange of ideas and expertise, contributing to the successful advancement of his research and innovations.

Conclusion: Hanping Feng's contributions to the field of biomedical research, particularly in developing therapies for Clostridium difficile infections, illustrate the importance of innovation in addressing pressing healthcare challenges. His patents represent a blend of scientific ingenuity and practical application, highlighting his role as a significant inventor in the medical community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…